IQ-AI Ltd - medical software company with headquarters in Jersey - Launches IB Stroke, completing key new product introduction. IB Stroke available as set of workflows processed by IB Rad Tech platform and provides users with flexibility to process both MR and CT perfusion image sets.
"The IB Stroke output may be used by clinicians to help determine the usefulness of treating the patient with clot-busting drugs - drugs which can potentially save oxygen-starved brain tissue but bring with them a host of potential side-effects," says IQ-AI.
Current stock price: 5.34 pence; up 10% on Thursday
Year-to-date change: up 35%
By Anna Farley; annafarley@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
IQ-AI (IQAI)